Long-Term Study Suggests Extended Relief from Atopic Dermatitis After Topical Treatment
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
The treatment is the first short-duration facial injectable available in the region for the temporary improvement of lines between the eyebrows.